Immediate Impact

2 from Science/Nature 52 standout
Sub-graph 1 of 23

Citing Papers

Therapeutic advances in rheumatoid arthritis
2024 Standout
Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
6 intermediate papers

Works of Sameer Kotak being referenced

The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
2017
Maintenance of remission with combination etanercept–DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access
2017
and 3 more

Author Peers

Author Last Decade Papers Cites
Sameer Kotak 449 392 150 263 34 995
Laura Durcan 746 83 127 115 33 1.2k
Taylor Blachley 124 843 48 522 54 1.2k
Avani Joshi 300 280 77 39 33 895
Natasha Singh 93 296 51 243 53 945
Daniel G. Arkfeld 294 39 138 116 34 852
Meifen Zhang 219 455 34 48 82 1.2k
Ahmad Al‐Sabbagh 174 84 60 104 46 1.2k
H. Michels 440 300 790 33 67 1.3k
Niveditha Mohan 466 46 167 47 14 1.0k
Kalliopi Fragiadaki 671 289 159 160 26 1.4k

All Works

Loading papers...

Rankless by CCL
2026